Executives On The Move: New C-Suite Changes At Amneal Pharmaceuticals, Lexicon Pharmaceuticals And Amicus Therapeutics
Executive Summary
Recent moves in the industry include changes at the top at Amneal Pharmaceuticals, plus new CEOs at Incendia Therapeutics and Nereid Therapeutics.
You may also be interested in...
Pipeline Watch: Eight Approvals And 15 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Sypre Therapeutics, Evelo Biosciences, Amylyx Pharmaceuticals And More
Recent executive moves in the industry include changes at the top at Spyre Therapeutics, Neopharmed Gentili and CytoDyn.
Pipeline Watch: 12 Approvals And Nine Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.